19932018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2018

Diagnosis and management of prefibrotic myelofibrosis

on Behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators, Jul 3 2018, In : Expert Review of Hematology. 11, 7, p. 537-545 9 p.

Research output: Contribution to journalReview article

2017

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

Rumi, E., Boveri, E., Bellini, M., Pietra, D., Ferretti, V. V., Sant'Antonio, E., Cavalloni, C., Casetti, I. C., Roncoroni, E., Ciboddo, M., Benvenuti, P., Landini, B., Fugazza, E., Troletti, D., Astori, C., Cazzola, M. & on Behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators, Jan 1 2017, In : Oncotarget. 8, 60, p. 101735-101744 10 p.

Research output: Contribution to journalArticle

Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms

Cavalloni, C., Rumi, E., Ferretti, V. V., Pietra, D., Roncoroni, E., Bellini, M., Ciboddo, M., Casetti, I. C., Landini, B., Fugazza, E., Troletti, D., Astori, C. & Cazzola, M., Jan 1 2017, In : Oncotarget. 8, 20, p. 33416-33421 6 p.

Research output: Contribution to journalArticle

2016

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms

Pietra, D., Rumi, E., Ferretti, V. V., Di Buduo, C. A., Milanesi, C., Cavalloni, C., Sant'Antonio, E., Abbonante, V., Moccia, F., Casetti, I. C., Bellini, M., Renna, M. C., Roncoroni, E., Fugazza, E., Astori, C., Boveri, E., Rosti, V., Barosi, G., Balduini, A. & Cazzola, M., Feb 1 2016, In : Leukemia. 30, 2, p. 431-438 8 p.

Research output: Contribution to journalArticle

LNK mutations in familial myeloproliferative neoplasms

Rumi, E., Harutyunyan, A. S., Pietra, D., Feenstra, J. D. M., Cavalloni, C., Roncoroni, E., Casetti, I., Bellini, M., Milanesi, C., Renna, M. C., Gotti, M., Astori, C., Kralovics, R. & Cazzola, M., Jul 7 2016, In : Blood. 128, 1, p. 144-5 2 p.

Research output: Contribution to journalArticle

2015

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

Rumi, E., Milosevic, J. D., Selleslag, D., Casetti, I., Lierman, E., Pietra, D., Cavalloni, C., Bellini, M., Milanesi, C., Dambruoso, I., Astori, C., Kralovics, R., Vandenberghe, P. & Cazzola, M., Jul 23 2015, In : Annals of Hematology. 94, 11, p. 1927-1928 2 p.

Research output: Contribution to journalArticle

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia

Rumi, E., Bertozzi, I., Casetti, I. C., Roncoroni, E., Cavalloni, C., Bellini, M., Sant’Antonio, E., Gotti, M., Ferretti, V. V., Milanesi, C., Peroni, E., Pietra, D., Astori, C., Randi, M. L. & Cazzola, M., Oct 31 2015, In : Haematologica. 100, 11, p. e443-e445

Research output: Contribution to journalArticle

2014

A novel germline JAK2 mutation in familial myeloproliferative neoplasms

Rumi, E., Harutyunyan, A. S., Casetti, I., Pietra, D., Nivarthi, H., Moriggl, R., Cleary, C., Bagienski, K., Astori, C., Bellini, M., Berg, T., Passamonti, F., Kralovics, R. & Cazzola, M., Jan 2014, In : American Journal of Hematology. 89, 1, p. 117-118 2 p.

Research output: Contribution to journalArticle

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Rumi, E., Harutyunyan, A. S., Pietra, D., Milosevic, J. D., Casetti, I. C., Bellini, M., Them, N. C. C., Cavalloni, C., Ferretti, V. V., Milanesi, C., Berg, T., Sant'Antonio, E., Boveri, E., Pascutto, C., Astori, C., Kralovics, R. & Cazzola, M., Apr 10 2014, In : Blood. 123, 15, p. 2416-2419 4 p.

Research output: Contribution to journalArticle

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

Rumi, E., Pietra, D., Pascutto, C., Guglielmelli, P., Martínez-Trillos, A., Casetti, I., Colomer, D., Pieri, L., Pratcorona, M., Rotunno, G., Sant'Antonio, E., Bellini, M., Cavalloni, C., Mannarelli, C., Milanesi, C., Boveri, E., Ferretti, V., Astori, C., Rosti, V., Cervantes, F. & 3 others, Barosi, G., Vannucchi, A. M. & Cazzola, M., Aug 14 2014, In : Blood. 124, 7, p. 1062-1069 8 p.

Research output: Contribution to journalArticle

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Rumi, E., Pietra, D., Ferretti, V., Klampfl, T., Harutyunyan, A. S., Milosevic, J. D., Them, N. C. C., Berg, T., Elena, C., Casetti, I. C., Milanesi, C., Sant'Antonio, E., Bellini, M., Fugazza, E., Renna, M. C., Boveri, E., Astori, C., Pascutto, C., Kralovics, R. & Cazzola, M., Mar 6 2014, In : Blood. 123, 10, p. 1544-1551 8 p.

Research output: Contribution to journalArticle

2013

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms.

Rumi, E., Pietra, D., Guglielmelli, P., Bordoni, R., Casetti, I., Milanesi, C., Sant'Antonio, E., Ferretti, V., Pancrazzi, A., Rotunno, G., Severgnini, M., Pietrelli, A., Astori, C., Fugazza, E., Pascutto, C., Boveri, E., Passamonti, F., De Bellis, G., Vannucchi, A., Cazzola, M. & 2 others, Associazione Italiana per la Ricerca sul Cancro Gruppo, I. P. L. R. S. C. G. & Italiano Malattie Mieloproliferative, M. M., May 23 2013, In : Blood. 121, 21, p. 4388-4395 8 p.

Research output: Contribution to journalArticle

2012
2011

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: A study of 1,915 patients

Rumi, E., Passamonti, F., Elena, C., Pietra, D., Arcaini, L., Astori, C., Zibellini, S., Boveri, E., Pascutto, C. & Lazzarino, M., Mar 2011, In : Haematologica. 96, 3, p. 454-458 5 p.

Research output: Contribution to journalArticle

2010

A prospective study of 338 patients with polycythemia vera: The impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications

Passamonti, F., Rumi, E., Pietra, D., Elena, C., Boveri, E., Arcaini, L., Roncoroni, E., Astori, C., Merli, M., Boggi, S., Pascutto, C., Lazzarino, M. & Cazzola, M., Sep 2010, In : Leukemia. 24, 9, p. 1574-1579 6 p.

Research output: Contribution to journalArticle

2009

Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection

Arcaini, L., Pascutto, C., Passamonti, F., Bruno, R., Merli, M., Rizzi, S., Orlandi, E., Astori, C., Rattotti, S., Paulli, M. & Lazzarino, M., May 1 2009, In : International Journal of Cancer. 124, 9, p. 2246-2249 4 p.

Research output: Contribution to journalArticle

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

Novara, F., Arcaini, L., Merli, M., Passamonti, F., Zibellini, S., Rizzi, S., Rattotti, S., Rumi, E., Pascutto, C., Vetro, A., Astori, C., Boveri, E., Lucioni, M., Paulli, M., Zuffardi, O. & Lazzarino, M., Nov 2009, In : Human Pathology. 40, 11, p. 1628-1637 10 p.

Research output: Contribution to journalArticle

Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires

Arcaini, L., Zibellini, S., Passamonti, F., Rattotti, S., Lucioni, M., Invernizzi, R., Merli, M., Rizzi, S., Boveri, E., Rumi, E., Astori, C., Picone, C., Varettoni, M., Pascutto, C., Paulli, M. & Lazzarino, M., May 2009, In : Blood cells, molecules & diseases. 42, 3, p. 286-291 6 p.

Research output: Contribution to journalArticle

2008

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients

Zappasodi, P., Nosari, A. M., Astori, C., Ciapanna, D., Bonfichi, M., Varettoni, M., Mangiacavalli, S., Morra, E., Lazzarino, M. & Corso, A., May 2008, In : Transfusion. 48, 5, p. 857-860 4 p.

Research output: Contribution to journalArticle

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: A study of 605 patients

Passamonti, F., Rumi, E., Arcaini, L., Boveri, E., Elena, C., Pietra, D., Boggi, S., Astori, C., Bernasconi, P., Varettoni, M., Brusamolino, E., Pascutto, C. & Lazzarino, M., Nov 2008, In : Haematologica. 93, 11, p. 1645-1651 7 p.

Research output: Contribution to journalArticle

Severe intestinal vasculitis in a patient under treatment with bortezomib

Mangiacavalli, S., Zappasodi, P., Castagnola, C., Astori, C., Varettoni, M., Lazzarino, M. & Corso, A., 2007, In : Annals of Hematology. 86, 12, p. 923-924 2 p.

Research output: Contribution to journalArticle

2006

Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia

Rumi, E., Passamonti, F., Boveri, E., De Amici, M., Astori, C., Braschi, M., Castagnola, C., Magrini, U., Cazzola, M. & Lazzarino, M., Feb 2006, In : American Journal of Hematology. 81, 2, p. 124-127 4 p.

Research output: Contribution to journalArticle

2005

Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma

Corso, A., Mangiacavalli, S., Nosari, A., Castagnola, C., Zappasodi, P., Cafro, A. M., Astori, C., Bonfichi, M., Varettoni, M., Rusconi, C., Troletti, D., Pascutto, C., Morra, E. & Lazzarino, M., Dec 2005, In : Bone Marrow Transplantation. 36, 11, p. 951-954 4 p.

Research output: Contribution to journalArticle

2004

Peripheral intraneutrophil diplococci in a case of meningococcemia.

Rumi, E., Astori, C., Casazza, A., Marone, P. & Bonfichi, M., Apr 2004, In : Haematologica. 89, 4

Research output: Contribution to journalArticle

2002

Advantages of using thalidomide for the management of patients with refractory myeloma

Corso, A., Lorenzi, A., Orlandi, E., Astori, C., Mangiacavalli, S. & Lazzarino, M., 2002, In : Haematologica. 87, 3, p. 327-328 2 p.

Research output: Contribution to journalArticle

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma

Lazzarino, M., Arcaini, L., Bernasconi, P., Alessandrino, E. P., Gargantini, L., Cairoli, R., Orlandi, E., Astori, C., Brusamolino, E., Pagnucco, G., Colombo, A. A., Calatroni, S., Iacona, I., Regazzi, M. B. & Morra, E., 2002, In : British Journal of Haematology. 116, 1, p. 229-235 7 p.

Research output: Contribution to journalArticle

Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance

Bernasconi, P., Cavigliano, P. M., Boni, M., Astori, C., Calatroni, S., Giardini, I., Rocca, B., Caresana, M., Crosetto, N., Lazzarino, M. & Bernasconi, C., 2002, In : British Journal of Haematology. 118, 2, p. 545-549 5 p.

Research output: Contribution to journalArticle

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis

Passamonti, F., Malabarba, L., Orlandi, E., Pascutto, C., Brusamolino, E., Astori, C., Baratè, C., Canevari, A., Corso, A., Bernasconi, P., Cazzola, M. & Lazzarino, M., 2002, In : British Journal of Haematology. 116, 4, p. 855-861 7 p.

Research output: Contribution to journalArticle

2001

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients

Corso, A., Arcaini, L., Mangiacavalli, S., Astori, C., Orlandi, E., Lorenzi, A., Passamonti, F., Klersy, C., Pascutto, C., Canevari-Sciorati, A. & Lazzarino, M., 2001, In : Haematologica. 86, 4, p. 394-398 5 p.

Research output: Contribution to journalArticle

2000

Cytogenetic and FISH analyses in five patients with hypoplastic bone marrow [5]

Bernasconi, P., Astori, C., Cavigliano, P. M., Boni, M., Malcovati, L., Calatroni, S., Caresana, M. & Bernasconi, C., 2000, In : Leukemia. 14, 7, p. 1322 1 p.

Research output: Contribution to journalArticle

Rituximab (IDEC-C2B8): Validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study

Iacona, I., Lazzarino, M., Avanzini, M. A., Rupolo, M., Arcaini, L., Astori, C., Lunghi, F., Orlandi, E., Morra, E., Zagonel, V. & Regazzi, M. B., Jun 2000, In : Therapeutic Drug Monitoring. 22, 3, p. 295-301 7 p.

Research output: Contribution to journalArticle

Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma

Bernasconi, P., Orlandi, E., Cavigliano, P., Calatroni, S., Boni, M., Astori, C., Pagnucco, G., Giglio, S., Caresana, M., Lazzarino, M. & Bernasconi, C., 2000, In : Haematologica. 85, 10, p. 1087-1091 5 p.

Research output: Contribution to journalArticle

Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radiotherapy: Analysis of efficacy and long-term toxicity

Brusamolino, E., Lunghi, F., Orlandi, E., Astori, C., Passamonti, F., Barate, C., Pagnucco, G., Baio, A., Franchini, P., Lazzarino, M. & Bernasconi, C., 2000, In : Haematologica. 85, 10, p. 1032-1039 8 p.

Research output: Contribution to journalArticle

Trisomy 11 and a complex t(11;11;22) in a patient with acute myelomonocytic leukemia (AML-M4) following myelodysplasia (MDS): A cytogenetic study of a mechanism of leukemogenesis

Bernasconi, P., Cavigliano, P. M., Boni, M., Malcovati, L., Astori, C., Castagnola, C., Pagnucco, G., Vanelli, L., Calatroni, S., Caresana, M., Lazzarino, M. & Bernasconi, C., Jan 15 2000, In : Cancer Genetics and Cytogenetics. 116, 2, p. 111-118 8 p.

Research output: Contribution to journalArticle

1999

A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) [4]

Bernasconi, P., Cavigliano, P. M., Boni, M., Malcovati, L., Calatroni, S., Astori, C., Caresana, M. & Bernasconi, C., 1999, In : Leukemia. 13, 3, p. 487-489 3 p.

Research output: Contribution to journalArticle

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma

Lazzarino, M., Orlandi, E., Montillo, M., Tedeschi, A., Pagnucco, G., Astori, C., Corso, A., Brusamolino, E., Simoncini, L., Morra, E. & Bernasconi, C., 1999, In : Annals of Oncology. 10, 1, p. 59-64 6 p.

Research output: Contribution to journalArticle

Transient response of myeloma clone to pamidronate therapy [8]

Corso, A., Astori, C., Orlandi, E., Zappasodi, P., Arcaini, L. & Bemasconi, C., 1999, In : Haematologica. 84, 8, p. 759-760 2 p.

Research output: Contribution to journalArticle

1998

A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome

Bernasconi, P., Cavigliano, P. M., Genini, E., Castagnola, C., Malcovati, L., Calatroni, S., Caresana, M., Boni, M., Alessandrino, E. P., Astori, C., Corso, A. & Bernasconi, C., Sep 1998, In : Cancer Genetics and Cytogenetics. 105, 2, p. 182-186 5 p.

Research output: Contribution to journalArticle

Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma

Orlandi, E., Lazzarino, M., Bernasconi, P., Astori, C. & Bernasconi, C., 1998, In : Haematologica. 83, 8, p. 758-759 2 p.

Research output: Contribution to journalArticle

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: Correlation with tumor parameters and disease activity

Lazzarino, M., Orlandi, E., Klersy, C., Astori, C., Brusamolino, E., Corso, A., Bellio, L., Gargantini, L., Morra, E. & Bernasconi, C., Feb 1 1998, In : Cancer. 82, 3, p. 576-582 7 p.

Research output: Contribution to journalArticle

1997

Assessment of chimerism in sex-mismatched allogeneic bone marrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? [3]

Bernasconi, P., Cavigliano, P. M., Genini, E., Alessandrino, E. P., Colombo, A., Klersy, C., Malcovati, L., Biaggi, G., Martinelli, G., Calatroni, S., Caresana, M., Boni, M., Astori, C. & Bernasconi, C., 1997, In : Leukemia. 11, 11, p. 1989-1990 2 p.

Research output: Contribution to journalArticle

Growth factors in the therapy of myelodisplasia: Biological aspects

Bonfichi, M., Astori, C., Alessandrino, E. P., Balduini, P. B. A., Castagnola, C., Brusamolino, E., Pagnucco, G., Canevari, A., Trucco, P. & Bernasconi, C., 1997, In : Leukemia and Lymphoma. 26, SUPPL. 1, p. 35-40 6 p.

Research output: Contribution to journalArticle

Nodular lymphocyte predominance Hodgkin's disease: Long-term observation reveals a continuous pattern of recurrence

Orlandi, E., Lazzarino, M., Brusamolino, E., Paulli, M., Astori, C., Magrini, U. & Bernasconi, C., 1997, In : Leukemia and Lymphoma. 26, 3-4, p. 359-368 10 p.

Research output: Contribution to journalArticle

Splenic marginal zone cell lymphoma involving liver and bone marrow. Report of a case with protracted follow-up, showing progressive disappearance of the lymphoma after splenectomy

Rosso, R., Castello, A., Colosini, G., Astori, C., Lazzarino, M. & Magrini, U., Jan 1996, In : Haematologica. 81, 1, p. 44-46 3 p.

Research output: Contribution to journalArticle

1995

Acute myeloid leukemia and diabetes insipidus: Results in 5 patients

Castagnola, C., Morra, E., Bernasconi, P., Astori, C., Santagostino, A. & Bernasconi, C., 1995, In : Acta Haematologica. 93, 1, p. 1-4 4 p.

Research output: Contribution to journalArticle

Chronic myelogenous leukemia and exposure to ionizing radiation - a retrospective study of 443 patients

Corso, A., Lazzarino, M., Morra, E., Merante, S., Astori, C., Bernasconi, P., Boni, M. & Bernasconi, C., Feb 1995, In : Annals of Hematology. 70, 2, p. 79-82 4 p.

Research output: Contribution to journalArticle